Orphanet: Ricerca per malattia/gene
x

Cerca un progetto di ricerca

* (*) campo obbligatorio

38 Risultato/i

Ordinato per

Finanziato da un ente associato a IRDiRC =

Progetti di ricerca

AUSTRIA

WIEN
WIEN

Impact of Age-Related Clonal Hematopoiesis on Evolution of Atherosclerosis in Chronic Myeloid Leukemia
Medizinische Universität Wien
Ludwig Boltzmann Institut für Hämatologie und Onkologie

AUSTRIA

WIEN
WIEN

CDK8 - a weapon to arm NK cells against leukemia
Veterinärmedizinische Universität Wien
Institut für Pharmakologie und Toxikologie

FRANCIA

ILE-DE-FRANCE
ORSAY

ONCOPLURISTEM: models of pluripotent stem cells from chronic myeloid leukemia (CML): generation of new therapeutic tools for screening
Université Paris-Sud
Esteam Pluripotent Stem Cell Core Facility & Ingestem Infrastructure

GERMANIA

Baden-Württemberg
MANNHEIM

CML Register Study: Observational study on the course of CML under the new first-line therapies - DE
Universitätsklinikum Mannheim
European Leukemia Net - Network Management Center

GERMANIA

Thüringen
JENA

Ponderosa: Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
Universitätsklinikum Jena
Klinik für Innere Medizin II - Abteilung Hämatologie und Internistische Onkologie

SPAGNA

Castilla - León
SALAMANCA

Finanziato da un ente associato a IRDiRCTherapeutic approaches in chronic myeloid leukemia using CRISPR-CAS9
IBSAL - Instituto de Investigación Biomédica de Salamanca
IBSAL - Unidad de Medicina Molecular

AUSTRIA

WIEN
WIEN

Mechanism of CALR mutants in Myeloproliferative Neoplasms
AKH BT 25.3
Ce-M-M- Research Center for Molecular Medicine of the Austrian Academy of Sciences

AUSTRIA

WIEN
WIEN

Special Research Program - SFB F47 Myleoproliferative Neoplasms
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FINLANDIA

Finland
HELSINKI

Finanziato da un ente associato a IRDiRCMolecular genetics and biology of myeloproliferative neoplasms and other myeloid malignancies
University of Helsinki
Department of Medical and Clinical Genetics

SPAGNA

Cataluña
BADALONA

Finanziato da un ente associato a IRDiRCApplication of massive sequencing (NGS) in the diagnosis and prognosis of myelodysplastic syndromes/myeloproliferative neoplasms
IJC - Instituto de Investigación contra la Leucemia Josep Carreras, Campus HGTiP
Grupo de investigación de síndromes mielodisplásicos

GERMANIA

Nordrhein-Westfalen
DÜSSELDORF

Finanziato da un ente associato a IRDiRCMyPred - Optimizing the Care of Young Individuals with Predisposition to Myeloid Neoplasia: Role of the hematopoietic niche (SP6)
Universitätsklinikum Düsseldorf
Klinik für Kinder-Onkologie, -Hämatologie und klinische Immunologie

SVIZZERA

Suisse Alémanique
ZÜRICH

The Swiss Pediatric Hematology/ Oncology Metabank - a network for precision medicine research
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCIA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

GERMANIA

Baden-Württemberg
HEIDELBERG

Finanziato da un ente associato a IRDiRCERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Progetti di ricerca multicentrici